FDA Reopens Comment Period for Gluten Free
The agency is overdue to finalize its gluten-free labeling rule since issuing the proposed rule in 2007.
Beginning August 3, FDA has reopened the comment period for its proposed gluten-free food-labeling rule. The comment period will remain open for 60 days.
The agency is overdue to finalize its gluten-free labeling rule since issuing the proposed rule in 2007. The agency has faced continued pressure to set standards that would establish the maximum gluten threshold for products labeled “gluten-free.”
Thus far, FDA has proposed that gluten-free foods cannot contain more than 20 parts per million (ppm) of gluten. It notes that this standard takes into account current technologies for detecting gluten in food and that “validated methods could not reliably detect the amount of gluten in a food when the level was less than 20 ppm.” Notably, the 20 ppm-standard matches those set by the Codex Alimentarius and by 27 countries in the EU.
Gluten is a protein found in wheat, rye, and barley. Those intolerant to gluten include celiac disease sufferers, which are estimate to include 1% of the U.S. population.
Read FDA’s offical statement here.
Read past Nutritional Outlook coverage on gluten-free labeling: http://www.nutritionaloutlook.com/article/gluten-free-guidancehttp://www.nutritionaloutlook.com/article/increasingly-gluten-free http://www.nutritionaloutlook.com/article/fda-considers-official-definition-gluten-free-foods
http://www.nutritionaloutlook.com/news/fast-growth-gluten-free-says-packaged-facts
The Nutritional Outlook Podcast Episode 34: Demystifying Prebiotics and Postbiotics
September 30th 2024In this episode of the Nutritional Outlook Podcast we are looking back on a webcast Nutritional Outlook hosted in May, called “Demystifying the Prebiotic and Postbiotic Markets.” During that event, Sandra Saville, director of education and communication for the International Probiotics Association and Dr. Jessica A. Younes, scientific director of the International Probiotics Association debunked myths about prebiotic and postbiotics, and defined the respective categories to help manufacturers better understand how to responsibly formulate and market prebiotic and postbiotic products.
Balchem’s Newest Launch Optifolin⁺® Brings Innovation to the Folate Market
September 19th 2024Supplement launches featuring 5-MTHF are on the rise with double digit growth. In this episode of Nutritional Outlook’s podcast, we explore Optifolin⁺, a new ingredient in the market that offers essential nutrition from prenatal through adulthood. Join us as we uncover the potential impact of the next evolution in folate, setting the stage for a healthier future.
Learn More About Our Probiotic Solutions for The Best of Starts
October 8th 2024At Lallemand Health Solutions, we offer innovative, evidence-based probiotic solutions for expectant mothers and babies. Discover how probiotics support the four key areas of early life development: gut health, immune maturation, cognitive development, and growth.
